Zobrazeno 1 - 10
of 94
pro vyhledávání: '"a disintegrin and metalloproteinase 10"'
Akademický článek
Tento výsledek nelze pro nepřihlášené uživatele zobrazit.
K zobrazení výsledku je třeba se přihlásit.
K zobrazení výsledku je třeba se přihlásit.
Autor:
Emiel P. C. van der Vorst, Sanne L. Maas, Kosta Theodorou, Linsey J. F. Peters, Han Jin, Timo Rademakers, Marion J. Gijbels, Mat Rousch, Yvonne Jansen, Christian Weber, Michael Lehrke, Corinna Lebherz, Daniela Yildiz, Andreas Ludwig, Jacob F. Bentzon, Erik A. L. Biessen, Marjo M. P. C. Donners
Publikováno v:
Frontiers in Cardiovascular Medicine, Vol 10 (2023)
IntroductionThe transmembrane protease A Disintegrin And Metalloproteinase 10 (ADAM10) displays a “pattern regulatory function,” by cleaving a range of membrane-bound proteins. In endothelium, it regulates barrier function, leukocyte recruitment
Externí odkaz:
https://doaj.org/article/f70375b98dbc4f308c54dc71482a5393
Akademický článek
Tento výsledek nelze pro nepřihlášené uživatele zobrazit.
K zobrazení výsledku je třeba se přihlásit.
K zobrazení výsledku je třeba se přihlásit.
Autor:
Yuanyuan Cheng, Lishuang Lin, Xiaoyan Li, Aiqi Lu, Chenjian Hou, Qian Wu, Xiaomu Hu, Zhongwen Zhou, Zhongqing Chen, Feng Tang
Publikováno v:
Cancer Cell International, Vol 21, Iss 1, Pp 1-15 (2021)
Abstract Background Triple-negative breast cancer (TNBC) is the most challenging breast cancer subtype to treat, because it is so aggressive with shorter survival. Chemotherapy remains the standard treatment due to the lack of specific and effective
Externí odkaz:
https://doaj.org/article/6e1e700382d54aaabda92f39b392f827
Autor:
Daniela Kugelmann, Maresa Anders, Anna M. Sigmund, Desalegn T. Egu, Ramona A. Eichkorn, Amir S. Yazdi, Miklós Sárdy, Michael Hertl, Dario Didona, Takashi Hashimoto, Jens Waschke
Publikováno v:
Frontiers in Immunology, Vol 13 (2022)
The severe autoimmune blistering disease Pemphigus vulgaris (PV) is mainly caused by autoantibodies (IgG) against desmoglein (Dsg) 3 and Dsg1. The mechanisms leading to the development of blisters are not fully understood, but intracellular signaling
Externí odkaz:
https://doaj.org/article/bf9ecf11ae6e48e982490804fb4a2c1c
Publikováno v:
Journal of Clinical and Diagnostic Research, Vol 16, Iss 1, Pp OC01-OC04 (2022)
Introduction: Excessive signalling via the Receptor for Advanced Glycation End products (RAGE) is implicated in inflammatory renal damage in Diabetic Nephropathy (DN). RAGE signaling is modulated by its soluble form (sRAGE) that arises due to ectodom
Externí odkaz:
https://doaj.org/article/ec22c4e4653a425e8d74bc117c89d2a9
Akademický článek
Tento výsledek nelze pro nepřihlášené uživatele zobrazit.
K zobrazení výsledku je třeba se přihlásit.
K zobrazení výsledku je třeba se přihlásit.
Autor:
van der Vorst, E.P.C., Maas, S.L., Theodorou, K., Peters, L.J.F., Jin, H., Rademakers, T., Gijbels, M.J., Rousch, M., Jansen, Y., Weber, C., Lehrke, M., Lebherz, C., Yildiz, D., Ludwig, A., Bentzon, J.F., Biessen, E.A.L., Donners, M.M.P.C.
Publikováno v:
Frontiers in cardiovascular medicine, 10:974918. Frontiers Media S.A.
IntroductionThe transmembrane protease A Disintegrin And Metalloproteinase 10 (ADAM10) displays a “pattern regulatory function,” by cleaving a range of membrane-bound proteins. In endothelium, it regulates barrier function, leukocyte recruitment
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::b11cbbc8a1337385d5189dc907e654c4
https://doi.org/10.3389/fcvm.2023.974918
https://doi.org/10.3389/fcvm.2023.974918
Autor:
Alexandra L. Matthews, Chek Ziu Koo, Justyna Szyroka, Neale Harrison, Aditi Kanhere, Michael G. Tomlinson
Publikováno v:
Frontiers in Immunology, Vol 9 (2018)
A disintegrin and metalloproteinase 10 (ADAM10) is a ubiquitous transmembrane protein that functions as a “molecular scissor” to cleave the extracellular regions from its transmembrane target proteins. ADAM10 is well characterized as the ligand-d
Externí odkaz:
https://doaj.org/article/890bcc48acbb413dbf995531b5a52048
Autor:
Feng Tang, Qian Wu, Aiqi Lu, Chenjian Hou, Xiaoyan Li, Xiaomu Hu, Zhongqing Chen, Zhongwen Zhou, Yuanyuan Cheng, Lishuang Lin
Publikováno v:
Cancer Cell International, Vol 21, Iss 1, Pp 1-15 (2021)
Cancer Cell International
Cancer Cell International
Background Triple-negative breast cancer (TNBC) is the most challenging breast cancer subtype to treat, because it is so aggressive with shorter survival. Chemotherapy remains the standard treatment due to the lack of specific and effective molecular
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::645b3cc82768b00156a3a7b1b539019b
https://doaj.org/article/6e1e700382d54aaabda92f39b392f827
https://doaj.org/article/6e1e700382d54aaabda92f39b392f827